“…The features listed above have been extensively described and confirmed in the literature, however, a joint approach to produce well adapting engineered osteoblasts and chondrocytes has hitherto not been the subject of review articles or book chapters. The present outline encompasses a combined literature review of phenomena to take into consideration when engineering such cells from stem cells (SCs): sources of SCs to use (Logeart-Avramoglou, Anagnostou et al 2005;van Osch, Brittberg et al 2009), genes or microRNAs to manipulate (Goldring, Tsuchimochi et al 2006;Betz 2008;Grundberg, Brandstrom et al 2008;Duggal, Fronsdal et al 2009;Gordeladze, Djouad et al 2009;Lin 2009;Granchi, Ochoa et al 2010;Herlofsen, Kuchler et al 2011), selection of gene and microRNA delivery systems (Saraf and Mikos 2006;Phillips, Gersbach et al 2007), choice of humoral growth factors to facilitate SC differentiation (Shahdadfar, Fronsdal et al 2005;Boeuf and Richter 2010;van der Kraan, Davidson et al 2010), selection of appropriate scaffolds to support "asymmetric" SC differentiation (Vinatier, Bouffi et al 2009;Oh, Kim et al 2010;Seidi, Ramalingam et al 2011), combination of stem cell niches and/or co-cultures to ensure organ mimicry reflecting proper cell-cell interactions (Grad and Salzmann 2009;Grellier, Bordenave et al 2009;Boeuf and Richter 2010;Tare, Kanczler et al 2010), mechano-stimulation of cells (Kelly and Jacobs 2010;Nowlan, Sharpe et al 2010), and three-dimensional (3D) organ printing (Williams 2009;Visconti, Kasyanov et al 2010). Furthermore, this review also discusses how to stabilize osteoblasts and chondrocytes obtained by differentiation of SCs, i.e.…”